News

In nuclear physics, "magic numbers" identify specific numbers of protons or neutrons that lead to especially stable nuclei.
HealthDay News — Muscle ultrasound can detect insulin resistance and lower muscle mass, according to a study published online June 12 in the Journal of Ultrasound Medicine.
| Jun. 24, 2025 20:30**Mixed Model for Repeated Measures (MMRM) Positive topline safety results for the Phase 2b QUALITY Maintenance Extension clinical trial Adverse events (AEs) and adverse events of ...
On average, the placebo monotherapy group regained 2.27% in fat mass, while the enobosarm monotherapy cohorts had a loss of fat mass of -0.27% for the 3mg and -0.50% for the 6mg doses.
--Veru has been granted a meeting with FDA to discuss the Phase 3 clinical program-- MIAMI, FL, June 24, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical ...
“Based on our Phase 2b QUALITY active weight loss portion of the study, enobosarm 3mg preserved 100% of lean mass, 99% of body weight loss was from fat, and preserved physical function as ...
MIAMI, FL, June 24, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic ...
CAMBRIDGE, MA, USA I June 18, 2025 I Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy ...
Patients receiving apitegromab with tirzepatide over 24 weeks showed a 54.9% preservation of lean mass (+4.2 lbs of lean mass) versus tirzepatide alone (p=0.001) Patients receiving apitegromab ...
CAMBRIDGE, Mass., June 18, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy ...
Teleflex (NYSE: TFX) + Teleflex Incorporated $122.089 0.46% Open 122.985 Day High 122.985 52 Week High 257.04 52 Week Low 176.78 reports new findings from a study showing the efficacy of its Arrow ...